U
CRTX

UBS’s CORNERSTONE THERAPEUTICS INC CRTX Stock Holding History

UBS’s Portfolio CRTX Stock Details CRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-400
Closed -$3K – 11155
2013
Q2 		$3K Buy
+400
New +$3.37K ﹤0.01% 9724

Other funds holding CRTX

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

UBS's CRTX Position: Q1 2014 in Review

UBS sold out of CORNERSTONE THERAPEUTICS INC (CRTX) in Q1 2014, closing a stake of 525 shares — an estimated $5K sold.

UBS first reported a position in CRTX in Q2 2013 and held it in 3 quarters. The position peaked at $52K in Q3 2013. 1 fund tracked by Wall St. Rank holds CRTX as of Q1 2014.

  • UBS reported no remaining CORNERSTONE THERAPEUTICS INC position as of Q1 2014 after selling out during the quarter.
  • UBS sold 525 CORNERSTONE THERAPEUTICS INC shares in Q1 2014, an estimated $5K.
  • UBS first reported a position in CORNERSTONE THERAPEUTICS INC in Q2 2013 and held it in 3 quarters.
  • UBS's CORNERSTONE THERAPEUTICS INC position peaked at $52K in Q3 2013.
  • 1 fund tracked by Wall St. Rank held CORNERSTONE THERAPEUTICS INC as of Q1 2014.

Based on UBS's 13F filing for Q1 2014, filed 15 May 2014.